MFDS — authorised 2 July 2020
- Marketing authorisation holder: ViiV Healthcare Company
- Status: likely_approved
🇰🇷 Rukobia in South Korea
MFDS authorised Rukobia on 2 July 2020
Marketing authorisation
Rukobia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Rukobia approved in South Korea?
Yes. MFDS authorised it on 2 July 2020.
Who is the marketing authorisation holder for Rukobia in South Korea?
ViiV Healthcare Company holds the South Korean marketing authorisation.